- Home
- EZGO vs THAR Comparison
EZGO vs THAR Comparison
Compare EZGO & THAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EZGO
- THAR
- Stock Information
- Founded
- EZGO 2014
- THAR 2017
- Country
- EZGO China
- THAR United States
- Employees
- EZGO N/A
- THAR N/A
- Industry
- EZGO Motor Vehicles
- THAR Biotechnology: Pharmaceutical Preparations
- Sector
- EZGO Consumer Discretionary
- THAR Health Care
- Exchange
- EZGO Nasdaq
- THAR Nasdaq
- Market Cap
- EZGO 2.0M
- THAR 2.4M
- IPO Year
- EZGO 2021
- THAR 2022
- Fundamental
- Price
- EZGO $0.47
- THAR $1.51
- Analyst Decision
- EZGO
- THAR Strong Buy
- Analyst Count
- EZGO 0
- THAR 1
- Target Price
- EZGO N/A
- THAR $17.00
- AVG Volume (30 Days)
- EZGO 169.4K
- THAR 197.2K
- Earning Date
- EZGO 05-20-2025
- THAR 05-20-2025
- Dividend Yield
- EZGO N/A
- THAR N/A
- EPS Growth
- EZGO N/A
- THAR N/A
- EPS
- EZGO N/A
- THAR N/A
- Revenue
- EZGO $21,134,425.00
- THAR N/A
- Revenue This Year
- EZGO N/A
- THAR N/A
- Revenue Next Year
- EZGO N/A
- THAR N/A
- P/E Ratio
- EZGO N/A
- THAR N/A
- Revenue Growth
- EZGO 32.75
- THAR N/A
- 52 Week Low
- EZGO $0.29
- THAR $0.95
- 52 Week High
- EZGO $2.14
- THAR $6.45
- Technical
- Relative Strength Index (RSI)
- EZGO 72.12
- THAR 55.92
- Support Level
- EZGO $0.31
- THAR $1.41
- Resistance Level
- EZGO $0.40
- THAR $1.89
- Average True Range (ATR)
- EZGO 0.03
- THAR 0.17
- MACD
- EZGO 0.02
- THAR 0.03
- Stochastic Oscillator
- EZGO 84.13
- THAR 52.20
About EZGO EZGO Technologies Ltd.
EZGO Technologies Ltd is engaged in the sale of e-bicycles and battery and e-bicycle rentals, complemented by the sale of battery packs, battery cell trading and charging pile business. Its product categories include e-bicycle, Intelligent unmanned patrol car, e-motorcycle and e-moped and urban style e-tricycle. Its segments include the Battery cells and packs, electronic control system and intelligent robot segment. and the E-bicycle sales segment. The company generates maximum revenue from the Battery cells and packs segment.
About THAR Tharimmune Inc.
Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset, known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.